YahooSeptember 1, 2026 at 10:03 AM NY3 days ago
Myriad Genetics shares fall 7.1% after Piper Sandler downgrade
Myriad Genetics (NASDAQ:MYGN) shares fell 7. 1% in pre-market trading to $2.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo
Companies in This Story
Related Stories
Jim Cramer Thinks This Struggling Stock Could See A “Big Earnings Acceleration”
Yahoo3 hours ago
Walmart, Target, and Kroger face growing retail crime issue
Yahoo3 hours ago
Cramer Says a Wave of 21 Year Olds on Robinhood Is the Only Reason This Market Has Not Cracked
Yahoo5 hours ago
Top Research Reports for Apple, Broadcom & Shell
Yahoo6 hours ago
Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
Yahoo6 hours ago